Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.
about
Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.Chiral kinase inhibitors.Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in ratsResilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.Nerve growth factor is primarily produced by GABAergic neurons of the adult rat cortex.The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.Neurotrophin receptor TrkC is an entry receptor for Trypanosoma cruzi in neural, glial, and epithelial cellsRac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease.Enhanced bioavailability of nerve growth factor with phytantriol lipid-based crystalline nanoparticles in cochleaNerve growth factor, neural stem cells and Alzheimer's disease.Cytoskeletal transport in the aging brain: focus on the cholinergic system.Endocytic mechanisms for targeted drug deliveryHSV-1 amplicon vectors: a promising and versatile tool for gene delivery.Genetic modification of stem cells for transplantation.Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.Beta-amyloid toxicity and reversal in embryonic rat septal neurons.Identification of critical residues within the conserved and specificity patches of nerve growth factor leading to survival or differentiationBeta-amyloid toxicity in embryonic rat astrocytes.The Emerging Therapeutic Role of NGF in Alzheimer's Disease.The brain-tumor related protein podoplanin regulates synaptic plasticity and hippocampus-dependent learning and memory.Can proline-rich polypeptide complex mimic the effect of nerve growth factor?The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor.Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia.Trypanosoma cruzi promotes neuronal and glial cell survival through the neurotrophic receptor TrkCNerve growth factor withdrawal-mediated apoptosis in naive and differentiated PC12 cells through p53/caspase-3-dependent and -independent pathways.Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats.Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures.Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation.Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways.Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential.The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders.Effect of NGF From Venom of Chinese Cobra (Naja Atra)on Chondrocytes Proliferation and Metabolism In Vitro.Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin.The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs.
P2860
Q30611779-34A69F01-F581-43B7-98CD-7CDE08176431Q33811207-E6B7EFA1-6DA9-476D-B900-7B2AE03DB68FQ33844890-66464761-4186-4CF4-9A68-97261A9A9EBEQ33895321-4FDF145C-3223-43F3-B515-07D758E7A98CQ33958289-C8C6CB56-1EB3-4285-B6D0-88FD06FA50F2Q34014060-021ACEF8-767E-4708-BDF6-B3C7DFEDC25CQ34412007-EBF150C6-7561-4C1A-A596-7B5B9760269FQ34459388-DCA72DB1-7A25-4546-9647-0BC9D5242F2FQ34725080-8F804473-C451-4754-B559-F7BA6D452959Q35162941-71F01994-E7E8-4E62-A8F4-FAE19454536BQ35273283-B41951B5-1388-4BDE-B86B-8B3CB929B00DQ35951970-CD905C4B-464C-40EB-B245-71D4C2F847D7Q35996424-05E3DADE-002C-4341-B463-F1DA0C4C4DB6Q36265255-9B2C223B-0130-48D6-B35B-074EFDBC6777Q36529555-0ABD922F-F2D9-474C-B61E-9FEC8601A5C7Q36729485-B0470A74-DABE-4DCF-AAB4-47C376FC327FQ36894849-594975C3-61C5-42DE-AEBE-676A612D4987Q36897379-605CF9CD-8851-431C-BBAF-3D95ADD5226CQ37010620-F4DBE98D-02AC-485B-A78F-518EAB34BEAAQ37318152-5EE3BB99-E73E-4AC2-A006-D62B431F2594Q37362146-19326054-9D06-47F0-BD7B-D920F0F90B61Q37446250-026C2F08-F7FA-4D52-ACE1-ED7E10590178Q37592514-2AEE106A-0A22-427C-B20F-427240826C03Q38708387-6C7E6A69-EE66-4E33-9686-94D9AD52AB36Q38828049-34484BA6-4171-4B8A-883B-9B23BA89902DQ38973809-C3D17B1F-E17E-404C-93C0-5F3C17403816Q39577698-332D51BC-71F1-401B-9E9C-69B581DBDC7CQ39595801-952B56DD-2359-402B-BD7A-E0149B3F2687Q39889598-15028928-A48B-4772-A326-B989A9F939B2Q40596476-6ED960A6-DDFC-4DAB-84ED-2198CF855FB0Q42483831-6CEDBAE3-40D2-4F50-9039-A3DAF58281A8Q44814173-F2239EEA-E152-4DB1-BD63-DC057C5B2867Q45054555-50AC40E3-5C40-4AF0-9766-9EF0616EF377Q45158274-CB3C09C0-2946-49D1-82D8-960F5A3C52B9Q46061859-57BD83FD-A053-4FBF-BDAF-1C8A1DB105DDQ47595268-A07B48CE-A766-486A-B3EA-192AE685FAB9Q48254879-C61E0DE6-FB01-43DE-A182-44D1F03E96EEQ48304534-D71A2381-B4DA-493C-BA4A-38EB0BCE2969Q48670584-8DBE907C-DEA2-4780-81E5-50B9E720572EQ48944762-73998A71-4701-439A-B868-C147F4FF7A24
P2860
Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@ast
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@en
type
label
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@ast
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@en
prefLabel
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@ast
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@en
P2093
P356
P1476
Nerve growth factor: structure ...... tions for Alzheimer's disease.
@en
P2093
Elliott J Mufson
Kenneth E Neet
Shivanand P Lad
P304
P356
10.2174/1568007033482724
P577
2003-10-01T00:00:00Z